Update shared on 14 May 2026
AMD remains one of the clearest second-place beneficiaries of the AI infrastructure buildout. Hyperscalers want a credible alternative to Nvidia, and AMD’s data-center CPUs, Instinct accelerators, and broader adaptive-computing portfolio give it a real path to take share as customers diversify suppliers.
The bull case is that AI accelerator revenue scales faster than expected, data-center margins expand, and AMD converts strong demand into durable earnings growth. If management executes, AMD could become a much larger AI infrastructure business than it was during the PC and gaming-led cycles.
The risk is valuation. After a very strong share-price move, the market is already pricing in major AI success. Competition from Nvidia, custom ASICs, and hyperscaler in-house silicon remains intense, while export controls and supply constraints could limit upside. I’m still positive on the long-term business, but the stock now needs excellent execution to justify the current price.
Have other thoughts on Advanced Micro Devices?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
QuanD is an employee of Simply Wall St, but has written this narrative in their capacity as an individual investor. QuanD has a position in NasdaqGS:AMD.. Simply Wall St has no position in any companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimate's are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.